Position in AZN
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$205,737
-$5,288 QoQ
Shares Held
1,085
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,185
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RDA Financial Network holds $10,624,897 across 8 Drug Manufacturers - General names. AZN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,517 | $5,417,825 | |
| 2 | PFE |
Pfizer Inc
|
69,539 | $1,674,499 | |
| 3 | JNJ |
Johnson & Johnson
|
5,338 | $1,355,691 | |
| 4 | ABBV |
AbbVie Inc.
|
3,122 | $785,620 | |
| 5 | BIIB |
Biogen Inc.
|
3,000 | $648,180 | |
| 6 | AMGN |
Amgen Inc
|
836 | $302,732 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,857 | $234,613 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,085 | $205,737 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,737 | 1,085 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $211,025 | 1,070 | Shares | Sole | 2026-04-08 | |
| No filing history on record for this holder in this stock. | ||||||